Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease - a podcast by JAMA Network

from 2019-12-16T16:00

:: ::

Interview with Charbel Moussa, MD, PhD, author of Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial

Further episodes of JAMA Neurology Author Interviews

Further podcasts by JAMA Network

Website of JAMA Network